RE, MARIA CARLA
 Distribuzione geografica
Continente #
NA - Nord America 10.702
EU - Europa 8.556
AS - Asia 8.373
AF - Africa 593
Continente sconosciuto - Info sul continente non disponibili 564
SA - Sud America 514
OC - Oceania 21
AN - Antartide 1
Totale 29.324
Nazione #
US - Stati Uniti d'America 10.541
SG - Singapore 2.400
VN - Vietnam 2.302
CN - Cina 1.900
IT - Italia 1.598
DE - Germania 1.336
GB - Regno Unito 1.291
NL - Olanda 1.264
SE - Svezia 1.085
HK - Hong Kong 591
FR - Francia 462
IN - India 427
BR - Brasile 351
RU - Federazione Russa 345
IE - Irlanda 274
UA - Ucraina 261
TG - Togo 184
JP - Giappone 126
ZA - Sudafrica 123
FI - Finlandia 102
CI - Costa d'Avorio 99
CA - Canada 97
BD - Bangladesh 94
BG - Bulgaria 86
JO - Giordania 86
EE - Estonia 85
NG - Nigeria 69
AR - Argentina 68
PH - Filippine 64
BE - Belgio 58
KR - Corea 57
ID - Indonesia 54
SC - Seychelles 54
AT - Austria 53
TH - Thailandia 46
CH - Svizzera 44
PL - Polonia 42
TR - Turchia 35
ES - Italia 29
HR - Croazia 29
MX - Messico 27
EC - Ecuador 23
IQ - Iraq 22
PK - Pakistan 21
PT - Portogallo 21
SA - Arabia Saudita 20
TW - Taiwan 20
CL - Cile 19
IR - Iran 19
MY - Malesia 18
UZ - Uzbekistan 18
CO - Colombia 17
LT - Lituania 17
AU - Australia 16
RO - Romania 16
LB - Libano 13
EG - Egitto 12
CZ - Repubblica Ceca 9
ET - Etiopia 9
GR - Grecia 9
PY - Paraguay 9
VE - Venezuela 9
RS - Serbia 8
HN - Honduras 7
IL - Israele 7
KZ - Kazakistan 7
PE - Perù 7
LY - Libia 6
DK - Danimarca 5
DZ - Algeria 5
MD - Moldavia 5
NP - Nepal 5
BO - Bolivia 4
CY - Cipro 4
EU - Europa 4
HU - Ungheria 4
KE - Kenya 4
MA - Marocco 4
NZ - Nuova Zelanda 4
PA - Panama 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AL - Albania 3
BB - Barbados 3
CG - Congo 3
GT - Guatemala 3
MK - Macedonia 3
SI - Slovenia 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BS - Bahamas 2
CM - Camerun 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
GE - Georgia 2
GY - Guiana 2
Totale 28.720
Città #
Singapore 1.684
Ashburn 1.139
Southend 1.082
Fairfield 909
Chandler 736
Kerkrade 648
San Jose 638
Hong Kong 543
Frankfurt am Main 524
Santa Clara 511
Ann Arbor 497
Ho Chi Minh City 473
Hanoi 437
Woodbridge 433
Seattle 425
Houston 415
Dong Ket 410
Wilmington 373
Eygelshoven 338
Princeton 337
Cambridge 330
Beijing 291
Dublin 274
Bologna 263
Boardman 248
Lomé 184
Lauterbourg 166
Jacksonville 147
Los Angeles 144
Westminster 130
Nanjing 129
Berlin 110
Milan 108
New York 108
Tokyo 105
Council Bluffs 103
Hefei 102
Abidjan 99
Padova 94
Turin 91
Dallas 90
Amman 85
Redmond 84
Sofia 82
Buffalo 75
Florence 69
Des Moines 68
San Diego 68
Helsinki 67
Jinan 67
Redondo Beach 65
São Paulo 65
Abeokuta 63
Haiphong 62
Da Nang 60
Shenyang 60
Rome 55
Brussels 54
Munich 53
Saint Petersburg 53
Bremen 51
Shanghai 50
Chicago 49
Guangzhou 48
Phoenix 47
Hebei 46
Tianjin 42
Seoul 38
London 36
Nanchang 35
Changsha 34
Nuremberg 34
Mülheim 31
Vienna 31
Zhengzhou 30
Dearborn 29
Falls Church 29
Hangzhou 29
Jakarta 29
Olalla 29
Bern 28
Orem 28
Redwood City 28
Montreal 27
Paris 26
Warsaw 26
Atlanta 25
Falkenstein 25
Toronto 25
Thái Nguyên 24
Ningbo 23
Verona 23
Yubileyny 23
Amsterdam 21
The Dalles 21
Biên Hòa 20
Naples 20
Bühl 19
Can Tho 19
Jiaxing 19
Totale 18.340
Nome #
18F-FDG PET/CT in visceral leishmaniasis: uptake patterns in the context of a multiannual outbreak in Northern Italy 1.746
ALTERAZIONI DEL MICROBIOMA FARINGEO IN CORSO DI INFEZIONI DA NEISSERIA GONORRHOEAE 396
Analisi della trasmissione di SARS-CoV-2: influenza delle condizioni termoigrometriche rispetto al rischio di diffusione del contagio 344
QuantiFERON-TB Gold Plus with Chemiluminescence Immunoassay: Do We Need a Higher Cutoff? 340
Pharyngeal Chlamydia and gonorrhea: a hidden problem 287
RILEVAZIONE DELLA STRUTTURA MOSAICO DEL GENE PENA IN SEDE ORO-FARINGEA 284
Restriction Factors expression decreases in HIV-1 patients after cART 277
IFI16 reduced expression is correlated with unfavorable outcome in chronic lymphocytic leukemia 269
Impact of meropenem on Klebsiella pneumoniae metabolism 252
Pre-Pregnancy Diet and Vaginal Environment in Caucasian Pregnant Women: An Exploratory Study 249
Serum antibodies against human intracisternal A-type particle (HIAP) endogenous retrovirus in Alopecia areata patients: a hallmark of autoimmune disease? 248
Analysis of the effects of HIV-1 Tat on the survival and differentiation of vessel wall-derived mesenchymal stem cells 246
Quantitative detection of human immunodeficiency virus type 1 (HIV-1) proviral DNA in peripheral blood mononuclear cells by SYBR green real-time PCR technique. 242
Comparison of the Aptima HIV-1 Quant Dx Assay with the COBAS® AmpliPrep/COBAS® TaqMan® HIV-1 v2.0 Test for HIV-1 Viral Load Quantification in Plasma Samples from HIV-1-Infected Patients. 242
Discordant resistance interpretations in multi-treated HIV-1 patients 238
Acute onset myopericarditis as unusual presentation of primary HIV infection 238
Mosaic structure of the penA gene in the oropharynx of men who have sex with men negative for gonorrhoea 238
Development of C-TILDA: A modified TILDA method for reservoir quantification in long term treated patients infected with subtype C HIV-1 236
IFI16 expression is related to selected transcription factors during B-cell differentiation 232
Conflicting interpretations of the prevalence of mutations associated with drug resistance in antiviral naive HIV-1 patients with acute and chronic infection 229
Low-dose doxycycline induces Chlamydia trachomatis persistence in HeLa cells 217
Serum antibody reactivity to human intracisternal A-type particle retrovirus proteins in systemic sclerosis patients 216
Improvement of Mycobacterium tuberculosis detection by Xpert MTB/RIF Ultra: A head-to-head comparison on Xpert-negative samples 214
Significant Decrease in Plasma Levels of D-Dimer, Interleukin-8, and Interleukin-12 After a 12-Month Treatment with Rosuvastatin in HIV-Infected Patients Under Antiretroviral Therapy 213
Autochthonous cases of mucosal leishmaniasis in Northeastern Italy: clinical management and novel treatment approaches 210
HIV-1 DNA proviral load in treated and untreated HIV-1 seropositive patients. 206
Pattern of arterial inflammation and inflammatory markers in people living with HIV compared with uninfected people 206
Calcaneal quantitative ultrasound (QUS) and dual X-ray absorptiometry (DXA) bone analysis in adult HIV-positive patients. 204
Subgingival periodontal pathogens in Down syndrome children without periodontal breakdown. A case-control study on deciduous teeth 203
Pharyngeal microbiome alterations during Neisseria gonorrhoeae infection 201
HIV-1 and recombinant gp120 affect the survival and differentiation of human vessel wall-derived mesenchymal stem cells 198
Asymptomatic Leishmania infantum infection in blood donors living in an endemic area, northeastern Italy 198
Encephalopathy in COVID-19 Presenting With Acute Aphasia Mimicking Stroke 198
Dual raltegravir-darunavir/ritonavir combination in virologically suppressed HIV-1-infected patients on antiretroviral therapy including a ritonavir-boosted protease inhibitor plus two nucleoside/nucleotide reverse transcriptase inhibitors 196
SARS-CoV-2/COVID-19 testing: The tower of babel 196
Impact of different antiretroviral strategies on total HIV-DNA level in virologically suppressed HIV-1 infected patients. 195
Peptide-derivatized SB105-A10 dendrimer inhibits the infectivity of R5 and X4 HIV-1 strains in primary PBMCs and cervicovaginal histocultures. 195
Monitoring the treatment of hepatitis C with directly acting antivirals by serological and molecular methods 195
Effects of Antiretroviral Molecules on Survival and Gene Expression of an Osteoblast-like Cell Line 193
Clinical application of Bruker Biotyper MALDI-TOF/MS system for real-time identification of KPC production in Klebsiella pneumoniae clinical isolates 193
Validation of a Cleanroom Compliant Sonication-Based Decellularization Technique: A New Concept in Nerve Allograft Production 192
Pharyngeal chlamydia and gonorrhoea: a hidden problem. 190
Antiretroviral molecules and cardiovascular diseases. 189
Bloodstream infection caused by KPC-producing Klebsiella pneumoniae resistant to ceftazidime/avibactam: epidemiology and genomic characterization 188
Analysis of the effects of specific protease inhibitors on OPG/RANKL regulation in an osteoblast-like cell line. 187
M48U1 and Tenofovir combination synergistically inhibits HIV infection in activated PBMCs and human cervicovaginal histocultures 186
Detection of serum antibodies to human intracisternal A-type retroviral particles in chronic idiopathic urticaria 185
Prevalence of R5 strains in multi-treated HIV subjects and impact of new regimens including maraviroc in a selected group of patients with CCR5-tropic HIV-1 infection. 185
Comparison of MycoPrep and the new MYCO-TB kit: rapid and efficient digestion and decontamination of respiratory specimens for the detection of Mycobacteria 185
HIV-1 DNA load analysis in peripheral blood lymphocytes and monocytes from naïve and HAART-treated individuals. 184
Serum hepatitis B core-related antigen is an effective tool to categorize patients with HBeAg-negative chronic hepatitis B 184
Incomplete IgG response to HIV-1 proteins and low avidity levels in recently converted HIV patients treated with early antiretroviral therapy. 184
HIV-1 early and late diagnosis in the Emilia Romagna Region (Italy): A three year study 183
Recent and long-lasting infections: the need for avidity testing in HIV-1 infected subjects. 182
Cap. 4- IL MICROBIOMA OCULARE E IMPATTO SUL SISTEMA IMMUNE 182
Antiviral activity of interferon-based combination therapy in critically ill patients with COVID-19: Preliminary observations 181
Rectal Microbiota Associated With Chlamydia trachomatis and Neisseria gonorrhoeae Infections in Men Having Sex With Other Men 179
High-throughput genotyping of high-risk Human Papillomavirus by MALDI-TOF Mass Spectrometry-based method. 178
Factors associated with vitamin D deficiency in HIV-1 infected patients on combination antiretroviral therapy: a case-control study. 178
Prevalence of hypovitaminosis D and factors associated with vitamin D deficiency and morbidity among HIV-infected patients enrolled in a large Italian cohort. 177
Host restriction factors and Human immunodeficiency Virus (HIV-1): a dynamic interplay involving all phases of the viral life cycle 177
Different patterns of HIV-1 DNA after therapy discontinuation 176
Quantitative DNA proviral detection in HIV-1 patients treated with antiretroviral therapy. 175
Genotypic resistance in plasma and peripheral blood lymphocytes in a group of naive HIV-1 patients. 174
Children and SARS-CoV-2 infection: innocent bystanders…until proven otherwise 174
HIV and kidney: A dangerous liaison 173
Total integration of cultural and molecular testing for CPE screening with liquid based microbiology (LBM) 173
Prospective evaluation of bone markers, parathormone and 1,25-(OH)₂ vitamin D in HIV-positive patients after the initiation of tenofovir/emtricitabine with atazanavir/ritonavir or efavirenz 172
HIV-1 Tat protein concomitantly down-regulates apical caspase-10 and up-regulates c-FLIP in lymphoid T cells: A potential molecular mechanism to escape TRAIL cytotoxicity 172
A large outbreak of giardiasis in a municipality of the Bologna province, north-eastern Italy, november 2018 to april 2019 172
Effects of human immunodeficiency virus on the erythrocyte and megakaryocyte lineages. 171
No correlation between statin exposure and incident diabetes mellitus in HIV-1-infected patients receiving combination antiretroviral therapy 171
Changes in Serum Markers of Inflammation and Endothelial Activation in HIV-Infected Antiretroviral Naive Patients Starting A Treatment with Abacavir-Lamivudine or Tenofovir-Emtricitabine Plus Efavirenz 171
Molecular Bases of Osteoporosis in HIV: The Role of the Virus and Antiretroviral Therapy 170
Low avidity antibody: a reliable method to diagnose a recent HIV-1 infection. 168
Comparative serum bactericidal activity of meropenem-based combination regimens against extended-spectrum beta-lactamase and KPC-producing Klebsiella pneumoniae 168
Human T-lymphotropic virus type 1 (HTLV-1) prevalence and quantitative detection of DNA proviral load in individuals with indeterminate/positive serological results 167
HIV-1 infection of a nurse from a newborn with an unknown HIV infection: a case report. 167
HIV-1 and HCV detection in dried blood spots by SYBR Green multiplex real-time RT-PCR. 166
HIV-related mechanisms in atherosclerosis and cardiovascular diseases. 166
HIV-1 coreceptor usage in paired plasma RNA and proviral DNA from patients with acute and chronic infection never treated with antiretroviral therapy 166
Bone alterations during HIV infection 165
Evaluation of HIV-DNA and inflammatory markers in HIV-infected individuals with different viral load patterns 165
Guidelines for the qualitative detection of viral genomes in dried blood spots. 164
Prevalence of antiretroviral drug resistance in untreated persons newly diagnosed with HIV-1 infection 164
Predictors of time to sputum smear conversion in patients with pulmonary tuberculosis under treatment 163
Improvement in insulin sensitivity and serum leptin concentration after the switch from a ritonavir-boosted PI to raltegravir or dolutegravir in non-diabetic HIV-infected patients 162
Screening strategies for the diagnosis of asymptomatic Leishmania infection in dialysis patients as a model for kidney transplant candidates 161
HIV-1 subtype C transmission network: The phylogenetic reconstruction strongly supports the epidemiological data. 161
Nevirapine prophylaxis to prevent HIV-1 mother-to-child transmission: pharmacokinetic considerations in preterm infants 160
In vitro interaction of ceftazidime–avibactam in combination with different antimicrobials against KPC-producing Klebsiella pneumoniae clinical isolates 159
Potential role of T2Candida in the management of empirical antifungal treatment in patients at high risk of candidaemia: a pilot single-centre study 159
HIV-1 gp120 impairs the differentiation and survival of cord blood CD34+ HPCs induced to the erythroid lineage. 157
Carbapenemase-producing Enterobacterales: changing epidemiology in a highly endemic Italian area 157
The Gut Microbiota of Critically Ill Patients With COVID-19 157
Molecular and phylogenetic analysis of HIV-1 variants circulating in Italy. 156
Durable viral suppression in an HIV-infected patient in the absence of antiretroviral therapy 155
An imported case of adult T cell leukemia in a HTLV-I-infected patient in Italy. 154
A novel IncA plasmid carrying blaVIM-1 in a Kluyvera cryocrescens strain 154
Effect of sugars on Chlamydia trachomatis infectivity 154
Totale 21.175
Categoria #
all - tutte 78.830
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 78.830


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.542 245 194 205 414 295 188 73 228 132 463 630 475
2022/20233.753 398 525 219 508 286 241 106 219 617 136 321 177
2023/20241.065 74 166 83 119 89 219 70 71 22 71 40 41
2024/20253.874 163 607 312 289 665 223 235 132 64 339 151 694
2025/20269.821 721 653 607 590 1.000 1.521 1.274 409 1.817 648 308 273
2026/2027178 178 0 0 0 0 0 0 0 0 0 0 0
Totale 29.324